OrbiMed’s TELA Bio TELA Stock Holding History

OrbiMed’s Portfolio TELA Stock Details TELA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,161,185	Closed	-$5.47M	–	139
2024 Q3	$5.47M	Sell	2,161,185 -296,357	-12%	-$1.05M	0.1%	97
2024 Q2	$11.6M	Sell	2,457,542 -378,000	-13%	-$1.99M	0.23%	70
2024 Q1	$16.1M	Hold	2,835,542	–	–	0.29%	72
2023 Q4	$18.8M	Hold	2,835,542	–	–	0.37%	64
2023 Q3	$22.7M	Hold	2,835,542	–	–	0.48%	59
2023 Q2	$28.7M	Sell	2,835,542 -192,000	-6%	-$1.96M	0.52%	57
2023 Q1	$32.2M	Hold	3,027,542	–	–	0.63%	51
2022 Q4	$34.8M	Hold	3,027,542	–	–	0.67%	53
2022 Q3	$25.8K	Hold	3,027,542	–	–	0.48%	63
2022 Q2	$21.2K	Hold	3,027,542	–	–	0.38%	59
2022 Q1	$35.2M	Hold	3,027,542	–	–	0.57%	50
2021 Q4	$38.8M	Hold	3,027,542	–	–	0.5%	57
2021 Q3	$41.4M	Hold	3,027,542	–	–	0.45%	61
2021 Q2	$48.8M	Hold	3,027,542	–	–	0.49%	58
2021 Q1	$45.1M	Hold	3,027,542	–	–	0.42%	66
2020 Q4	$45.5M	Hold	3,027,542	–	–	0.4%	64
2020 Q3	$50.1M	Hold	3,027,542	–	–	0.63%	47
2020 Q2	$39.2M	Hold	3,027,542	–	–	0.55%	54
2020 Q1	$23.7M	Hold	3,027,542	–	–	0.4%	59
2019 Q4	$39.2M	Buy	+3,027,542	New	+$37M	0.56%	52

Other funds holding TELA

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

OrbiMed's TELA Position: Q4 2024 in Review

OrbiMed sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 2,161,185 shares — an estimated $5.47M sold.

OrbiMed first reported a position in TELA in Q4 2019 and held it in 20 quarters. The position peaked at $50.1M in Q3 2020. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

OrbiMed reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
OrbiMed sold 2,161,185 TELA Bio shares in Q4 2024, an estimated $5.47M.
OrbiMed first reported a position in TELA Bio in Q4 2019 and held it in 20 quarters.
OrbiMed's TELA Bio position peaked at $50.1M in Q3 2020.
47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on OrbiMed's 13F filing for Q4 2024, filed 14 Feb 2025.